Budesonide 3 MG Delayed Release Oral Capsule — RxCUI 1244214
RxNorm drug concept · Semantic clinical drug
RxCUI 1244214
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
26 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1244214
Official nameBudesonide 3 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped26
Reported Medicaid activity (SDUD)44,768 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Budesonide Nasal Spray: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It temporarily relieves hay fever and other upper respiratory allergy symptoms. That means nasal congestion, runny nose, itchy nose and sneezing.
- Some symptoms may improve on the first day. It can take up to two weeks of daily use to get the most relief. If you aren't better after two weeks, stop and talk to a doctor.
- Shake the bottle well, then spray into your nose while sniffing gently. Prime a new bottle first, and again if you haven't used it in two days. Don't spray into your eyes or mouth,...
- Children 6 to under 12 can use it with an adult supervising. It's not for children under 6. It may slow growth in some children, so check with their doctor if they need it for more...
🕸️ Concept Web — How Budesonide 3 MG Delayed Release Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Budesonide 3 MG Delayed Release Oral Capsule
RxCUI 1244214 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Budesonide
19831IN
-
Budesonide
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Budesonide Delayed Release Oral Capsule
1489770SCDF -
Budesonide Oral Product
1151338SCDG -
Budesonide Pill
1151339SCDG -
Delayed Release Oral Capsule
316995DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Budesonide Delayed Release Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Budesonide 3 MG
332685SCDC
-
Budesonide 3 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Budesonide 3 MG
SCDC · 332685 -
Budesonide Delayed Release Oral Capsule
SCDF · 1489770 -
Budesonide Oral Product
SCDG · 1151338 -
Budesonide Pill
SCDG · 1151339
📦 FDA Products & Package NDCs
12 products · 26 package NDCs
26 package NDCs map to RxCUI 1244214 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00574-9855-10 | 1 BOTTLE in 1 CARTON (0574-9855-10) / 100 CAPSULE in 1 BOTT... | budesonide | Padagis US LLC | 2018-06-29 |
| 00904-7313-10 | 20 BLISTER PACK in 1 CARTON (0904-7313-10) / 1 CAPSULE, COA... | budesonide | Major Pharmaceuticals | 2024-09-03 |
| 16714-0829-01 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (16714-829-01) | budesonide | Northstar Rx LLC. | 2018-06-25 |
| 51407-0591-01 | 100 CAPSULE in 1 BOTTLE (51407-591-01) | budesonide | Golden State Medical Supply, Inc. | 2024-10-24 |
| 53746-0778-10 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (53746-778-10) | Budesonide | Amneal Pharmaceuticals of New York LLC | 2025-05-22 |
| 60687-0596-32 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-596-32) / 1 CAPS... | Budesonide | American Health Packaging | 2021-03-09 |
| 63629-8294-01 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (63629-8294-1) | Budesonide | Bryant Ranch Prepack | 2020-02-06 |
| 65162-0778-10 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-10) | Budesonide | Amneal Pharmaceuticals LLC | 2017-09-15 |
| 65162-0778-18 | 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-18) | Budesonide | Amneal Pharmaceuticals LLC | 2017-09-15 |
| 65162-0778-30 | 300 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-30) | Budesonide | Amneal Pharmaceuticals LLC | 2017-09-15 |
| 65162-0778-49 | 21 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-49) | Budesonide | Amneal Pharmaceuticals LLC | 2017-09-15 |
| 68382-0720-01 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-01) | budesonide | Zydus Pharmaceuticals USA Inc. | 2017-06-08 |
| 68382-0720-05 | 500 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-05) | budesonide | Zydus Pharmaceuticals USA Inc. | 2017-06-08 |
| 68382-0720-06 | 30 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-06) | budesonide | Zydus Pharmaceuticals USA Inc. | 2017-06-08 |
| 68382-0720-10 | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-10) | budesonide | Zydus Pharmaceuticals USA Inc. | 2017-06-08 |
| 68382-0720-16 | 90 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-16) | budesonide | Zydus Pharmaceuticals USA Inc. | 2017-06-08 |
| 68382-0720-77 | 10 BLISTER PACK in 1 CARTON (68382-720-77) / 10 CAPSULE, CO... | budesonide | Zydus Pharmaceuticals USA Inc. | 2017-06-08 |
| 70518-4613-00 | 50 POUCH in 1 BOX (70518-4613-0) / 1 CAPSULE, COATED PELLET... | budesonide | REMEDYREPACK INC. | 2026-04-23 |
| 70771-1075-00 | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-0) | budesonide | Zydus Lifesciences Limited | 2017-06-08 |
| 70771-1075-01 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-1) | budesonide | Zydus Lifesciences Limited | 2017-06-08 |
| 70771-1075-03 | 30 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-3) | budesonide | Zydus Lifesciences Limited | 2017-06-08 |
| 70771-1075-04 | 10 BLISTER PACK in 1 CARTON (70771-1075-4) / 10 CAPSULE, CO... | budesonide | Zydus Lifesciences Limited | 2017-06-08 |
| 70771-1075-05 | 500 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-5) | budesonide | Zydus Lifesciences Limited | 2017-06-08 |
| 70771-1075-09 | 90 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-9) | budesonide | Zydus Lifesciences Limited | 2017-06-08 |
| 72162-2473-01 | 1 BOTTLE in 1 CARTON (72162-2473-1) / 100 CAPSULE in 1 BOTT... | budesonide | Bryant Ranch Prepack | 2025-04-24 |
| 72162-2473-02 | 1 BOTTLE in 1 CARTON (72162-2473-2) / 100 CAPSULE in 1 BOTT... | budesonide | Bryant Ranch Prepack | 2025-04-24 |
Observed labelers:
Zydus Lifesciences Limited (6) ·
Zydus Pharmaceuticals USA Inc. (6) ·
Amneal Pharmaceuticals LLC (4) ·
Bryant Ranch Prepack (3) ·
American Health Packaging (1) ·
Amneal Pharmaceuticals of New York LLC (1)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.